The store will not work correctly when cookies are disabled.
(6,6-Dimethyl-hept-2-en-4-ynyl)-methyl-(3-methylsulfanyl-benzo[b]thiophen-7-ylmethyl)-amine hydrochloride
ID: ALA542035
PubChem CID: 45262781
Max Phase: Preclinical
Molecular Formula: C20H26ClNS2
Molecular Weight: 343.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1csc2c(CN(C)C/C=C/C#CC(C)(C)C)cccc12.Cl
Standard InChI: InChI=1S/C20H25NS2.ClH/c1-20(2,3)12-7-6-8-13-21(4)14-16-10-9-11-17-18(22-5)15-23-19(16)17;/h6,8-11,15H,13-14H2,1-5H3;1H/b8-6+;
Standard InChI Key: QEHDLZGTZLQAFD-WVLIHFOGSA-N
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
6.1552 4.1839 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8749 8.2840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1713 9.0401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 3.0138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5785 7.5278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4677 9.7963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5842 6.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 3.7700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2878 5.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4631 10.9963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5094 9.2006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5045 10.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3352 3.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3606 -2.8684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 0
2 5 2 0
4 6 1 0
3 7 1 0
6 7 2 0
8 9 3 0
5 10 1 0
8 11 1 0
9 12 1 0
11 13 2 0
6 14 1 0
10 15 1 0
4 16 2 0
5 17 1 0
13 18 1 0
15 18 1 0
16 19 1 0
17 19 2 0
12 20 1 0
12 21 1 0
12 22 1 0
15 23 1 0
14 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.56 | Molecular Weight (Monoisotopic): 343.1428 | AlogP: 5.66 | #Rotatable Bonds: 5 |
Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.74 | CX LogP: 6.04 | CX LogD: 4.69 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.51 | Np Likeness Score: -0.37 |
References
1. Nussbaumer P, Petranyi G, Stütz A.. (1991) Synthesis and structure-activity relationships of benzo[b]thienylallylamine antimycotics., 34 (1): [PMID:1992153] [10.1021/jm00105a011] |